IP Library › Assignment 048932/0651

Patent Assignment

Reel/Frame 048932/0651

Assignment of Assignor's Interest

Recorded: 2019-04-17 Pages: 13

View PDF Order Certified Copy

Assignors

THE P.F. LABORATORIES, INC.

Executed: 2019-04-08

PURDUE PHARMA TECHNOLOGIES, INC.

Executed: 2019-04-08

Assignee

PURDUE PHARMA L.P.

ONE STAMFORD FORUM, 201 TRESSER BOULEVARD, STAMFORD, CONNECTICUT, 06901

Covered Properties (74)

Pharmaceutical formulation containing gelling agent

Application: 10/214,412 →

Publication: US 2003/0068375

Pharmaceutical Composition Containing Gelling Agent

Patent: 8,389,007 →

Application: 12/262,015 →

Publication: US 2009/0081287

Pharmaceutical formulation containing gelling agent

Application: 12/653,115 →

Publication: US 2010/0168148

Pharmaceutical Formulation Containing Gelling Agent

Patent: 8,337,888 →

Application: 13/349,449 →

Publication: US 2012/0108622

Pharmaceutical Formulation Containing Gelling Agent

Patent: 9,060,976 →

Application: 13/726,324 →

Publication: US 2013/0217716

Pharmaceutical Formulation Containing Gelling Agent

Patent: 9,040,084 →

Application: 13/765,368 →

Publication: US 2013/0261143

Pharmaceutical Formulation Containing Gelling Agent

Patent: 9,308,170 →

Application: 13/890,874 →

Publication: US 2013/0245055

Pharmaceutical Formulation Containing Gelling Agent

Patent: 8,609,683 →

Application: 13/905,922 →

Publication: US 2013/0261144

Pharmaceutical Formulation Containing Gelling Agent

Patent: 8,529,948 →

Application: 13/905,931 →

Publication: US 2013/0261145

Pharmaceutical Formulation Containing Gelling Agent

Patent: 8,999,961 →

Application: 13/946,418 →

Publication: US 2013/0303494

Pharmaceutical Formulation Containing Gelling Agent

Application: 14/243,580 →

Publication: US 2014/0213606

Pharmaceutical Formulation Containing Gelling Agent

Patent: 8,871,265 →

Application: 14/255,502 →

Publication: US 2014/0228390

Pharmaceutical Formulation Containing Gelling Agent

Patent: 9,034,376 →

Application: 14/460,134 →

Publication: US 2014/0357657

Pharmaceutical Formulation Containing Gelling Agent

Application: 14/460,170 →

Publication: US 2014/0371257

Pharmaceutical Formulation Containing Gelling Agent

Application: 14/470,631 →

Publication: US 2015/0005331

Pharmaceutical Formulation Containing Opioid Agonist, Opioid Antagonist and Gelling Agent

Application: 14/470,662 →

Publication: US 2015/0031718

Pharmaceutical Formulation Containing Gelling Agent

Patent: 9,044,435 →

Application: 14/484,077 →

Publication: US 2015/0005333

Pharmaceutical Formulation Containing Gelling Agent

Application: 14/605,034 →

Publication: US 2015/0140083

Pharmaceutical Formulation Containing Gelling Agent

Patent: 9,308,171 →

Application: 14/610,156 →

Publication: US 2015/0148319

Pharmaceutical Formulation Containing Gelling Agent

Application: 14/611,716 →

Publication: US 2015/0147391

Pharmaceutical Formulation Containing Gelling Agent

Patent: 9,867,783 →

Application: 14/638,685 →

Publication: US 2015/0238481

Pharmaceutical Formulation Containing Gelling Agent

Patent: 9,387,173 →

Application: 14/658,285 →

Publication: US 2015/0182628

Pharmaceutical Formulation Containing Gelling Agent

Application: 14/728,601 →

Publication: US 2015/0283250

Pharmaceutical Formulation Containing Gelling Agent

Application: 14/730,002 →

Publication: US 2015/0283128

Pharmaceutical Formulation Containing Gelling Agent

Application: 14/730,003 →

Publication: US 2015/0283129

Pharmaceutical Formulation Containing Gelling Agent

Application: 14/730,016 →

Publication: US 2015/0283130

Pharmaceutical Formulation Containing Gelling Agent

Application: 14/730,017 →

Publication: US 2015/0273064

Pharmaceutical Formulation Containing Gelling Agent

Application: 14/730,021 →

Publication: US 2015/0273065

Pharmaceutical Formulation Containing Gelling Agent

Application: 14/733,654 →

Publication: US 2015/0265606

Pharmaceutical Formulation Containing Gelling Agent

Application: 14/733,647 →

Publication: US 2015/0265605

Pharmaceutical Formulation Containing Gelling Agent

Application: 14/733,659 →

Publication: US 2015/0265607

Pharmaceutical Formulation Containing Gelling Agent

Application: 14/846,021 →

Publication: US 2015/0374631

Pharmaceutical Formulation Containing Gelling Agent

Patent: 9,387,174 →

Application: 14/851,575 →

Publication: US 2016/0000723

Pharmaceutical Formulation Containing Gelling Agent

Patent: 9,517,207 →

Application: 14/851,727 →

Publication: US 2015/0374628

Pharmaceutical Formulation Containing Gelling Agent

Application: 14/852,157 →

Publication: US 2016/0000712

Pharmaceutical Formulation Containing Gelling Agent

Application: 14/852,236 →

Publication: US 2016/0058716

Pharmaceutical Formulation Containing Gelling Agent

Application: 14/856,386 →

Publication: US 2016/0000718

Pharmaceutical Formulation Containing Gelling Agent

Application: 14/856,388 →

Publication: US 2016/0000719

Pharmaceutical Formulation Containing Gelling Agent

Application: 14/856,392 →

Publication: US 2016/0000776

Pharmaceutical Formulation Containing Gelling Agent

Application: 14/856,394 →

Publication: US 2016/0000717

Pharmaceutical Formulation Containing Gelling Agent

Patent: 10,071,057 →

Application: 15/013,628 →

Publication: US 2016/0151499

Pharmaceutical Formulation Containing Gelling Agent

Application: 15/015,708 →

Publication: US 2016/0151502

Pharmaceutical Formulation Containing Gelling Agent

Patent: 9,693,961 →

Application: 15/015,722 →

Publication: US 2016/0151355

Pharmaceutical Formulation Containing Gelling Agent

Patent: 9,872,836 →

Application: 15/015,735 →

Publication: US 2016/0151356

Pharmaceutical Formulation Containing Gelling Agent

Patent: 10,076,497 →

Application: 15/015,763 →

Publication: US 2016/0151357

Pharmaceutical Formulation Containing Gelling Agent

Patent: 9,861,582 →

Application: 15/015,769 →

Publication: US 2016/0151358

Pharmaceutical Formulation Containing Gelling Agent

Patent: 9,867,784 →

Application: 15/019,195 →

Publication: US 2016/0151277

Pharmaceutical Formulation Containing Gelling Agent

Application: 15/019,222 →

Publication: US 2016/0151360

Pharmaceutical Formulation Containing Gelling Agent

Patent: 10,064,824 →

Application: 15/019,281 →

Publication: US 2016/0151289

Pharmaceutical Formulation Containing Gelling Agent

Patent: 9,968,559 →

Application: 15/019,304 →

Publication: US 2016/0151297

Pharmaceutical Formulation Containing Gelling Agent

Application: 15/019,315 →

Publication: US 2016/0151290

Pharmaceutical Formulation Containing Gelling Agent

Application: 15/019,321 →

Publication: US 2016/0151291

Pharmaceutical Formulation Containing Gelling Agent

Patent: 9,877,924 →

Application: 15/284,706 →

Publication: US 2017/0020863

Pharmaceutical Formulation Containing Gelling Agent

Patent: 9,757,341 →

Application: 15/284,711 →

Publication: US 2017/0020864

Pharmaceutical Formulation Containing Gelling Agent

Application: 15/354,473 →

Publication: US 2017/0065524

Pharmaceutical Formulation Containing Gelling Agent

Patent: 9,861,583 →

Application: 15/354,538 →

Publication: US 2017/0065525

Pharmaceutical Formulation Containing Gelling Agent

Patent: 10,130,586 →

Application: 15/345,979 →

Publication: US 2017/0112765

Pharmaceutical Formulation Containing Gelling Agent

Application: 15/637,703 →

Publication: US 2017/0296533

Pharmaceutical Formulation Containing Gelling Agent

Patent: 10,064,825 →

Application: 15/702,127 →

Publication: US 2018/0021262

Pharmaceutical Formulation Containing Gelling Agent

Patent: 10,206,881 →

Application: 15/803,370 →

Publication: US 2018/0055771

Pharmaceutical Formulation Containing Gelling Agent

Application: 15/877,917 →

Publication: US 2018/0147151

Pharmaceutical Formulation Containing Gelling Agent

Application: 15/865,832 →

Publication: US 2018/0125788

Pharmaceutical Formulation Containing Gelling Agent

Patent: 10,500,160 →

Application: 16/121,242 →

Publication: US 2019/0070119

Pharmaceutical Formulation Containing Gelling Agent

Application: 16/133,993 →

Publication: US 2019/0015341

Pharmaceutical Formulation Containing Gelling Agent

Application: 16/163,076 →

Publication: US 2019/0110996

Pharmaceutical Formulation Containing Gelling Agent

Patent: 10,537,526 →

Application: 16/229,188 →

Publication: US 2019/0117580

Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent

Application: 60/310,537 →

Pharmaceutical Formulation Containing Opioid Agonist,Opioid Antagonist and Gelling Agent

Patent: 7,842,307 →

Application: 10/214,413 →

Publication: US 2003/0068371

Pharmaceutical Formulations Containing Opioid Agonist, Opioid Antagonist and Gelling Agent

Patent: 8,524,275 →

Application: 12/909,527 →

Publication: US 2011/0230510

Pharmaceutical Formulation Containing Opioid Agonist, Opioid Antagonist and Gelling Agent

Patent: 9,101,668 →

Application: 13/956,467 →

Publication: US 2013/0317051

Pharmaceutical Formulation Containing Opioid Agonist, Opioid Antagonist and Gelling Agent

Patent: 9,561,225 →

Application: 14/793,174 →

Publication: US 2016/0008350

Pharmaceutical Formulation Containing Opioid Agonist, Opioid Antagonist and Gelling Agent

Patent: 9,808,453 →

Application: 15/384,229 →

Publication: US 2017/0157115

Pharmaceutical Formulation Containing Opioid Agonist, Opioid Antagonist and Gelling Agent

Application: 15/724,869 →

Publication: US 2018/0021330

Pharmaceutical Formulation Containing Gelling Agent

Application: 14/733,634 →

Publication: US 2015/0265603

Related Assignments (8)

Other recorded transfers of the patents in this record — the chain of ownership.

Assignment of Assignor's Interest Oct 15, 2002

From: WRIGHT, CURTIS; OSHLACK, BENJAMIN; BREDER, CHRISTOPHER

To: EURO-CELTIQUE S.A.

Reel/Frame 013382/0536 →

Assignment of Assignor's Interest Dec 12, 2007

From: EURO-CELTIQUE S.A.

To: PURDUE PHARMA L.P.

Reel/Frame 020238/0720 →

Assignment of Assignor's Interest Dec 21, 2012

From: PURDUE PHARMA L.P.

To: PURDUE PHARMA L.P.; THE P.F. LABORATORIES, INC.; PURDUE PHARMACEUTICALS L.P.

Reel/Frame 029515/0964 →

Assignment of Assignor's Interest Jun 4, 2014

From: PURDUE PHARMA L.P.

To: PURDUE PHARMA L.P.; THE P.F. LABORATORIES, INC.; PURDUE PHARMACEUTICALS L.P.

Reel/Frame 033024/0305 →

Assignment of Assignor's Interest Oct 1, 2014

From: PURDUE PHARMA L.P.

To: PURDUE PHARMA L.P.; THE P.F. LABORATORIES, INC.; PURDUE PHARMACEUTICALS L.P.

Reel/Frame 033865/0420 →

Assignment of Assignor's Interest Oct 1, 2014

From: PURDUE PHARMA L.P.

To: PURDUE PHARMA L.P.; THE P.F. LABORATORIES, INC.; PURDUE PHARMACEUTICALS L.P.

Reel/Frame 033865/0459 →

Assignment of Assignor's Interest Oct 1, 2014

From: PURDUE PHARAMA L.P.

To: PURDUE PHARMA L.P.; THE P.F. LABORATORIES, INC.; PURDUE PHARMACEUTICALS L.P.

Reel/Frame 033865/0455 →

Assignment of Assignor's Interest Oct 1, 2014

From: PURDUE PHARMA L.P.

To: PURDUE PHARMA L.P.; THE P.F. LABORATORIES, INC.; PURDUE PHARMACEUTICALS L.P.

Reel/Frame 033865/0441 →